Cathay Industrial Biotech

Cathay Industrial Biotech

Chinese biotech company producing bio-based materials like long-chain dibasic acids and biopolyamides for sustainable plastics and textiles.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor

€0.0

round
investor

€0.0

round
N/A

CNY5.6b

Valuation: CNY8.2b

5.5x EV/Revenue

12.6x EV/EBITDA

IPO
Total Funding000k
BVCF
BVCF(exited)
NEA
NEA(exited)
HBM Partners
HBM Partners(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
CNY201920202021202220232024
Revenues000000000000000000000000
% growth-(22 %)47 %11 %(13 %)40 %
EBITDA000000000000000000000000
% EBITDA margin35 %43 %43 %42 %37 %33 %
Profit000000000000000000000000
% profit margin25 %31 %28 %23 %17 %17 %
EV000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget000000000000000000000000
R&D % of revenue5 %6 %6 %8 %9 %8 %

Source: Company filings or news article

Notes (0)
More about Cathay Industrial Biotech
Made with AI
Edit

Cathay Industrial Biotech operates as a publicly-traded company on the Shanghai Stock Exchange's STAR market, specializing in the research, development, production, and sale of bio-based materials through synthetic biology and bio-manufacturing. The company was founded in 2000 by Dr. Xiucai Liu, who serves as the Chairman and CEO. Dr. Liu's background includes a Ph.D. in Biochemistry from the University of Wisconsin-Milwaukee and postdoctoral positions at Yale and Columbia, providing a strong scientific foundation for the company's focus on industrial biotechnology. A key milestone was the company's IPO on the STAR market in August 2020.

The core of Cathay's business is the production of alternatives to petrochemical-based products, utilizing renewable resources like corn and other crop stalks. Revenue is generated through direct sales of its bio-based products and through strategic partnerships for technology and product development. The company's business model is vertically integrated, spanning from monomer production to polymer synthesis, serving a global client base that includes prominent companies like DuPont, Evonik, and Novo Nordisk. Cathay's primary offerings include a series of long-chain dicarboxylic acids (LCDAs), bio-based pentamethylene diamine (PDA), and bio-based polyamides. The company is a world-leading supplier of bio-manufactured LCDAs, which are used in applications such as nylons, resins, adhesives, and fragrances.

Cathay's main product lines are its bio-based monomers and its subsequent polyamide brands, TERRYL® for textiles and ECOPENT® for engineering applications. The bio-based polyamides (PA5X series) are created from the company's own bio-manufactured PDA and various diacids. These materials offer distinct properties such as inherent flame retardance, high toughness, and low moisture absorption, which stem from their odd-numbered carbon molecular structure. This positions them as sustainable alternatives in markets like automotive, electronics, textiles, and consumer goods, aiming to reduce carbon emissions compared to traditional petroleum-based nylons.

Keywords: synthetic biology, bio-based materials, industrial biotechnology, polyamides, long-chain dicarboxylic acids, pentamethylene diamine, bio-manufacturing, renewable feedstock, chemical alternatives, biomaterials, sustainable chemicals, bioplastics, fermentation process, bio-based polymers, green chemistry, bio-composites, engineering plastics, specialty chemicals, textile materials, automotive materials

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Cathay Industrial Biotech

Edit